Sex differences in response to lithium treatment.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 10964872.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although sex differences occur with some psychotropic drug treatments, they are not well defined for mood-stabilizing agents, including lithium. The authors' goal was to investigate whether there are differences between the sexes in response to lithium. Studies identified in a literature search were analyzed for reports of sex differences in clinical response to lithium in major affective syndromes. Data from 17 studies published in 1967-1998, involving 1,548 adults treated with lithium for a mean of 38.6 months (SD=30.5), yielded similar weighted response rates to lithium in 1,043 women (65.6% [N=684]) and 505 men (61.0% [N=308]). The results indicate little difference between the sexes in clinical response to lithium treatment of bipolar and related affective disorders.
Medical subject headings
- Depressive Disorder
- Lithium